Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Breast Cancer Research and Treatment
|
August 1, 2016
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622
Anne F Schott, William E Barlow, Catherine H Van Poznak, et al.
Pharmacogenomics
|
December 7, 2018
Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure
Lauren A Marcath, Kelley M Kidwell, Adam C Robinson, et al.
Breast Cancer Research and Treatment
|
July 8, 2021
Improving the delivery of team-based survivorship care after primary breast cancer treatment through a multi-level intervention: a pilot randomized controlled trial
Lauren P Wallner, Paul Abrahamse, Joan G Gargaro, et al.
Annals of Surgical Oncology
|
September 12, 2008
Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence
Kandice E Kilbride, M Catherine Lee, Alexis V Nees, et al.
The Oncologist
|
January 24, 2012
Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430
Anne F Schott, William E Barlow, Kathy S Albain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2018
Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy
Daniel L Hertz, Kelley M Kidwell, Kiran Vangipuram, et al.
Breast Cancer Research and Treatment
|
September 3, 2021
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
Lori J Goldstein, Mauro Mansutti, Christelle Levy, et al.
Breast Cancer Research and Treatment
|
September 13, 2005
Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy
Anne F Schott, Marilyn A Roubidoux, Mark A Helvie, et al.
Translational Oncology
|
April 29, 2014
Image registration for quantitative parametric response mapping of cancer treatment response
Jennifer L Boes, Benjamin A Hoff, Nola Hylton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 29, 2009
Fever and neutropenia clinical practice guidelines
Alison G Freifeld, Lindsey Robert Baden, Arthur E Brown, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Breast Cancer Research and Treatment
|
August 1, 2016
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622
Anne F Schott, William E Barlow, Catherine H Van Poznak, et al.
Pharmacogenomics
|
December 7, 2018
Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure
Lauren A Marcath, Kelley M Kidwell, Adam C Robinson, et al.
Breast Cancer Research and Treatment
|
July 8, 2021
Improving the delivery of team-based survivorship care after primary breast cancer treatment through a multi-level intervention: a pilot randomized controlled trial
Lauren P Wallner, Paul Abrahamse, Joan G Gargaro, et al.
Annals of Surgical Oncology
|
September 12, 2008
Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence
Kandice E Kilbride, M Catherine Lee, Alexis V Nees, et al.
The Oncologist
|
January 24, 2012
Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430
Anne F Schott, William E Barlow, Kathy S Albain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2018
Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy
Daniel L Hertz, Kelley M Kidwell, Kiran Vangipuram, et al.
Breast Cancer Research and Treatment
|
September 3, 2021
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
Lori J Goldstein, Mauro Mansutti, Christelle Levy, et al.
Breast Cancer Research and Treatment
|
September 13, 2005
Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy
Anne F Schott, Marilyn A Roubidoux, Mark A Helvie, et al.
Translational Oncology
|
April 29, 2014
Image registration for quantitative parametric response mapping of cancer treatment response
Jennifer L Boes, Benjamin A Hoff, Nola Hylton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 29, 2009
Fever and neutropenia clinical practice guidelines
Alison G Freifeld, Lindsey Robert Baden, Arthur E Brown, et al.
Page
of 7